Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Cancer
Interventions: DRUG: larotaxel|DRUG: capecitabine
Sponsor: Sanofi